BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kushner RF. Weight Loss Strategies for Treatment of Obesity: Lifestyle Management and Pharmacotherapy. Prog Cardiovasc Dis 2018;61:246-52. [PMID: 29890171 DOI: 10.1016/j.pcad.2018.06.001] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 11.3] [Reference Citation Analysis]
Number Citing Articles
1 Hanson P, Barber TM. Non‐Surgical Management of Obesity. Handbook of Metabolic and Bariatric Surgery 2022. [DOI: 10.1002/9781119521686.ch5] [Reference Citation Analysis]
2 Yin Y, Zhao Q, Li S, Jiang H, Yin C, Chen H, Zhang Y. Efficacy of acupuncture and moxibustion therapy for simple obesity in adults: A meta-analysis of randomized controlled trials. Medicine (Baltimore) 2022;101:e31148. [PMID: 36316908 DOI: 10.1097/MD.0000000000031148] [Reference Citation Analysis]
3 Abiri B, Ramezani Ahmadi A, Ebadinejad A, Hosseinpanah F, Valizadeh M. Effects of sodium-glucose co-transporter-2 inhibitors on anthropometric indices and metabolic markers in overweight/obese individuals without diabetes: a systematic review and meta-analysis. Curr Med Res Opin 2022;:1-29. [PMID: 35993873 DOI: 10.1080/03007995.2022.2115775] [Reference Citation Analysis]
4 Kazim AH, Al-Ruwaybiah AM, Al-Naami MY, Aldohayan A, Binjaloud AA, Alarfaj MA. The Social Problems of Morbidly Obese Patients on a Community Level: A Cross-Sectional Study in Saudi Arabia. Diabetes Metab Syndr Obes 2022;15:2061-75. [PMID: 35873531 DOI: 10.2147/DMSO.S366358] [Reference Citation Analysis]
5 Vosburg RW, Chaar ME, Djouzi SE, Docimo S, Choi D, Lamasters T, Srivastava G, Shukla AP, Oviedo RJ, Fitch A, Azagury DE. Literature review on anti-obesity medication use for metabolic and bariatric surgery patients from the ASMBS clinical issues committee. Surgery for Obesity and Related Diseases 2022. [DOI: 10.1016/j.soard.2022.07.002] [Reference Citation Analysis]
6 Manu P, Lăcătuşu CM, Rogozea LM, Cernea S. Pharmacological Management of Obesity: A Century of Expert Opinions in Cecil Textbook of Medicine. Am J Ther 2022. [PMID: 35687055 DOI: 10.1097/MJT.0000000000001524] [Reference Citation Analysis]
7 Huang J, Zhao L, Sun J, Wang L, Gu J, Liu X, Yang M, Wang Y, Zhang N, Zhu J, Xu S, Ren X, Su Y. Clinical Evidence and Potential Mechanisms of Complementary Treatment of Ling Gui Zhu Gan Formula for the Management of Serum Lipids and Obesity. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-20. [DOI: 10.1155/2022/7714034] [Reference Citation Analysis]
8 Arias A, Rodríguez-Álvarez C, González-Dávila E, Acosta-Torrecilla A, Novo-Muñoz MM, Rodríguez-Novo N. Arterial Hypertension in Morbid Obesity after Bariatric Surgery: Five Years of Follow-Up, a Before-And-After Study. Int J Environ Res Public Health 2022;19:1575. [PMID: 35162597 DOI: 10.3390/ijerph19031575] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Kermansaravi M, Lainas P, Shahmiri SS, Yang W, Jazi AD, Vilallonga R, Antozzi L, Parmar C, Kassir R, Chiappetta S, Zubiaga L, Vitiello A, Mahawar K, Carbajo M, Musella M, Shikora S. The first survey addressing patients with BMI over 50: a survey of 789 bariatric surgeons. Surg Endosc. [DOI: 10.1007/s00464-021-08979-w] [Reference Citation Analysis]
10 Yang Z, Wang H, Liu N, Zhao K, Sheng Y, Pang H, Shao K, Zhang M, Li S, He N. Algal polysaccharides and derivatives as potential therapeutics for obesity and related metabolic diseases. Food Funct 2022. [DOI: 10.1039/d2fo02185d] [Reference Citation Analysis]
11 Mishra J, Amin K, Kuang L, Kumar N. Gut Microbiome and Obesity: Connecting Link. Microbial Engineering for Therapeutics 2022. [DOI: 10.1007/978-981-19-3979-2_4] [Reference Citation Analysis]
12 Mehta A, Shah SL, Saunders KH, Sharaiha RZ. Obesity Diagnosis and Pathophysiology. Nutrition, Weight, and Digestive Health 2022. [DOI: 10.1007/978-3-030-94953-2_12] [Reference Citation Analysis]
13 Kolli S, Tchang BG, Redmond IP, Barenbaum S, Saunders KH. Clinical Evaluation, Lifestyle, and Pharmacological Management of Obesity. Nutrition, Weight, and Digestive Health 2022. [DOI: 10.1007/978-3-030-94953-2_14] [Reference Citation Analysis]
14 Marzola E, Musso M, Abbate-daga G. Psychotropic Drug-Induced Disordered Eating Behaviors. Hidden and Lesser-known Disordered Eating Behaviors in Medical and Psychiatric Conditions 2022. [DOI: 10.1007/978-3-030-81174-7_8] [Reference Citation Analysis]
15 Davis LL, Nolan MZ. The Influence of Obesity on Care of Adults with Cardiovascular Disease. Nurs Clin North Am 2021;56:511-25. [PMID: 34749891 DOI: 10.1016/j.cnur.2021.07.002] [Reference Citation Analysis]
16 Gaesser GA, Angadi SS. Obesity treatment: Weight loss versus increasing fitness and physical activity for reducing health risks. iScience 2021;24:102995. [PMID: 34755078 DOI: 10.1016/j.isci.2021.102995] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 19.0] [Reference Citation Analysis]
17 Micioni Di Bonaventura MV, Coman MM, Tomassoni D, Micioni Di Bonaventura E, Botticelli L, Gabrielli MG, Rossolini GM, Di Pilato V, Cecchini C, Amedei A, Silvi S, Verdenelli MC, Cifani C. Supplementation with Lactiplantibacillus plantarum IMC 510 Modifies Microbiota Composition and Prevents Body Weight Gain Induced by Cafeteria Diet in Rats. Int J Mol Sci 2021;22:11171. [PMID: 34681831 DOI: 10.3390/ijms222011171] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Guerra JVS, Dias MMG, Brilhante AJVC, Terra MF, García-Arévalo M, Figueira ACM. Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases. Nutrients 2021;13:2830. [PMID: 34444990 DOI: 10.3390/nu13082830] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
19 Sieczkowska SM, de Lima AP, Swinton PA, Dolan E, Roschel H, Gualano B. Health Coaching Strategies for Weight Loss: A Systematic Review and Meta-Analysis. Adv Nutr 2021;12:1449-60. [PMID: 33339042 DOI: 10.1093/advances/nmaa159] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
20 Huang D, Zhang Z, Dong Z, Liu R, Huang J, Xu G. Caloric restriction and Roux-en-Y Gastric Bypass promote white adipose tissue browning in mice. J Endocrinol Invest 2021. [PMID: 34232475 DOI: 10.1007/s40618-021-01626-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Nguyen AD. Impact of bariatric surgery on gastroesophageal reflux disease and esophageal motility. Curr Opin Gastroenterol 2021;37:364-71. [PMID: 33859102 DOI: 10.1097/MOG.0000000000000745] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Kang JH, Kim H, Kim J, Seo JH, Cha S, Oh H, Kim K, Park SJ, Kim E, Kong S, Lee JH, Bae JS, Won HH, Joung JG, Yang YJ, Kim J, Park WY. Interaction of genetic and environmental factors for body fat mass control: observational study for lifestyle modification and genotyping. Sci Rep 2021;11:13180. [PMID: 34162918 DOI: 10.1038/s41598-021-92229-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Mao Y, Hong K, Bhandari S, Li L, Liao W, Kim S, Xiong Y, Nam I, Choe S, Kwak S. Ambient temperature regulates uncoupling protein 1 expression but fails to induce adipocyte browning in zebrafish. ADV TRADIT MED (ADTM) 2021;21:379-87. [DOI: 10.1007/s13596-021-00580-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Chu XY, Zhang CC, Zhang RX, Zhang JF, Xia B, Wu JW. Identification of Dacinostat as a potential anti-obesity compound through transcriptional activation of adipose thermogenesis in mice. Biochim Biophys Acta Mol Basis Dis 2021;1867:166169. [PMID: 34000373 DOI: 10.1016/j.bbadis.2021.166169] [Reference Citation Analysis]
25 Haenisch M, Nguyen T, Fihn CA, Goldstein AS, Amory JK, Treuting P, Brabb T, Paik J. Investigation of an ALDH1A1-specific inhibitor for suppression of weight gain in a diet-induced mouse model of obesity. Int J Obes (Lond) 2021;45:1542-52. [PMID: 33934107 DOI: 10.1038/s41366-021-00818-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
26 van Son J, Koekkoek LL, La Fleur SE, Serlie MJ, Nieuwdorp M. The Role of the Gut Microbiota in the Gut-Brain Axis in Obesity: Mechanisms and Future Implications. Int J Mol Sci 2021;22:2993. [PMID: 33804250 DOI: 10.3390/ijms22062993] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
27 Vieira RFL, Muñoz VR, Junqueira RL, de Oliveira F, Gaspar RC, Nakandakari SCBR, Costa SO, Torsoni MA, da Silva ASR, Cintra DE, de Moura LP, Ropelle ER, Zaghloul I, Mekary RA, Pauli JR. Time-restricted feeding combined with aerobic exercise training can prevent weight gain and improve metabolic disorders in mice fed a high-fat diet. J Physiol 2021. [PMID: 33450053 DOI: 10.1113/JP280820] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
28 Heymsfield SB, Coleman LA, Miller R, Rooks DS, Laurent D, Petricoul O, Praestgaard J, Swan T, Wade T, Perry RG, Goodpaster BH, Roubenoff R. Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity: A Phase 2 Randomized Clinical Trial. JAMA Netw Open 2021;4:e2033457. [PMID: 33439265 DOI: 10.1001/jamanetworkopen.2020.33457] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 38.0] [Reference Citation Analysis]
29 Kalyanasundar B, Perez CI, Arroyo B, Moreno MG, Gutierrez R. The Appetite Suppressant D-norpseudoephedrine (Cathine) Acts via D1/D2-Like Dopamine Receptors in the Nucleus Accumbens Shell. Front Neurosci 2020;14:572328. [PMID: 33177980 DOI: 10.3389/fnins.2020.572328] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Park JS, Lee WK, Kim HS, Seo JA, Kim DH, Han HC, Min BH. Clusterin overexpression protects against western diet-induced obesity and NAFLD. Sci Rep 2020;10:17484. [PMID: 33060605 DOI: 10.1038/s41598-020-73927-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
31 Chopra S, Malhotra A, Ranjan P, Vikram NK, Singh N. Lifestyle-related advice in the management of obesity: A step-wise approach. J Educ Health Promot 2020;9:239. [PMID: 33209931 DOI: 10.4103/jehp.jehp_216_20] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
32 Lomax TM, Ashraf S, Yilmaz G, Harmancey R. Loss of Uncoupling Protein 3 Attenuates Western Diet-Induced Obesity, Systemic Inflammation, and Insulin Resistance in Rats. Obesity (Silver Spring) 2020;28:1687-97. [PMID: 32716607 DOI: 10.1002/oby.22879] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
33 Safahani M, Aligholi H, Asadi-Pooya AA. Management of antiepileptic drug-induced nutrition-related adverse effects. Neurol Sci 2020;41:3491-502. [PMID: 32661886 DOI: 10.1007/s10072-020-04573-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
34 Lavie CJ. Statistics 2020 at progress in cardiovascular diseases. Progress in Cardiovascular Diseases 2020;63:534-5. [DOI: 10.1016/j.pcad.2020.07.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Westerterp-Plantenga MS. Challenging energy balance - during sensitivity to food reward and modulatory factors implying a risk for overweight - during body weight management including dietary restraint and medium-high protein diets. Physiol Behav 2020;221:112879. [PMID: 32199999 DOI: 10.1016/j.physbeh.2020.112879] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
36 Poku C, Tahsin B, Fogelfeld L. Weight loss: Lifestyle interventions and pharmacotherapy. Obesity Hypoventilation Syndrome 2020. [DOI: 10.1016/b978-0-12-815290-4.00016-6] [Reference Citation Analysis]
37 Rodríguez-Álvarez C, Acosta-Torrecilla AO, González-Dávila E, Arias Á. Metabolic syndrome after Roux-en-Y gastric bypass in patients with morbid obesity: Five years of follow-up, a before and after study. Int J Surg 2020;74:5-10. [PMID: 31874260 DOI: 10.1016/j.ijsu.2019.12.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
38 Jones ES, Nunn N, Chambers AP, Østergaard S, Wulff BS, Luckman SM. Modified Peptide YY Molecule Attenuates the Activity of NPY/AgRP Neurons and Reduces Food Intake in Male Mice. Endocrinology 2019;160:2737-47. [PMID: 31074796 DOI: 10.1210/en.2019-00100] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
39 Martinez-Gomez D, Lavie CJ, Hamer M, Cabanas-Sanchez V, Garcia-Esquinas E, Pareja-Galeano H, Struijk E, Sadarangani KP, Ortega FB, Rodríguez-Artalejo F. Physical activity without weight loss reduces the development of cardiovascular disease risk factors - a prospective cohort study of more than one hundred thousand adults. Prog Cardiovasc Dis 2019;62:522-30. [PMID: 31758975 DOI: 10.1016/j.pcad.2019.11.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
40 Safavi R, Lih A, Kirkpatrick S, Haller S, Bailony MR. Impact of anti-obesity medication initiation and duration on weight loss in a comprehensive weight loss programme. Obes Sci Pract 2019;5:468-78. [PMID: 31687171 DOI: 10.1002/osp4.361] [Reference Citation Analysis]
41 Rubio Herrera MA, Fernández-García JM, Corio Andújar R, Santos Altozano C, Urieta Carpi JJ. [Pharmacological treatment of obesity for Primary Care physicians]. Semergen 2019;45:559-65. [PMID: 31350172 DOI: 10.1016/j.semerg.2019.04.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
42 Gouni-Berthold I, Berthold HK. Current Options for the Pharmacotherapy of Obesity. Curr Pharm Des 2019;25:2019-32. [PMID: 31298150 DOI: 10.2174/1381612825666190708192630] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
43 Lavie CJ. Continuing with Good Statistics at Progress in Cardiovascular Diseases. Progress in Cardiovascular Diseases 2019;62:370-2. [DOI: 10.1016/j.pcad.2019.07.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
44 Lunsky IO, Meyre D. Decoding Mendelian obesity. Current Opinion in Endocrine and Metabolic Research 2019;4:21-8. [DOI: 10.1016/j.coemr.2018.10.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
45 Wang J, Geng L. Effects of Socioeconomic Status on Physical and Psychological Health: Lifestyle as a Mediator. Int J Environ Res Public Health 2019;16:E281. [PMID: 30669511 DOI: 10.3390/ijerph16020281] [Cited by in Crossref: 80] [Cited by in F6Publishing: 87] [Article Influence: 26.7] [Reference Citation Analysis]
46 Severin R, Sabbahi A, Mahmoud AM, Arena R, Phillips SA. Precision Medicine in Weight Loss and Healthy Living. Prog Cardiovasc Dis 2019;62:15-20. [PMID: 30610881 DOI: 10.1016/j.pcad.2018.12.012] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
47 Lavie CJ. Five Years as Editor-in-Chief. Progress in Cardiovascular Diseases 2019;62:83-84. [DOI: 10.1016/j.pcad.2019.01.001] [Reference Citation Analysis]
48 Laferrère B, Pattou F. Weight-Independent Mechanisms of Glucose Control After Roux-en-Y Gastric Bypass. Front Endocrinol (Lausanne) 2018;9:530. [PMID: 30250454 DOI: 10.3389/fendo.2018.00530] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]